Tag Archives: another

AstraZeneca, Merck's Lynparza posts pancreatic cancer win in another PARP-class first

AstraZeneca and Merck’s Lynparza has already led its class into two disease areas, and now it’s looking to make it three. Tuesday, the companies said their PARP inhibitor had topped placebo at staving off progression of tough-to-treat pancreatic cancer in patients with germline BRCA-mutated forms of the disease. The phase 3 study, dubbed POLO, examined Lynparza in… Read More »

Apple Could Be Facing Another China Headache – Motley Fool

The ongoing trade war between the United States and China could be set to take a significant toll on Apple‘s (NASDAQ:AAPL) business. Per a report from Nikkei Asian Review, following the arrest of Huawei CFO Meng Wanzhou in Canada at the request of the United States, “[many] Chinese businesses have told employees they will receive subsidies if… Read More »